Quikhale FB 200 Capsule - Bottle of 30

Quikhale FB 200 Capsule is a specialized formulation designed for the management of chronic obstructive pulmonary disease (COPD). This medication combines two potent active ingredients: Formoterol and Budesonide. Formoterol is a long-acting bronchodilator that works by relaxing the muscles in the airways, thereby widening them and facilitating easier breathing. Budesonide, on the other hand, is a corticosteroid that helps reduce inflammation in the airways by inhibiting the release of certain chemical messengers responsible for swelling. Together, these components make Quikhale FB 200 Capsule an effective therapy for individuals suffering from COPD. The primary purpose of Quikhale FB 200 Capsule is to alleviate symptoms associated with COPD, such as shortness of breath, wheezing, and chronic cough. By addressing both the bronchoconstriction and inflammation aspects of the disease, Quikhale FB 200 Capsule provides comprehensive relief to patients. This combination therapy falls under the therapeutic category of respiratory medications, specifically targeting chronic respiratory conditions. Patients using Quikhale FB 200 Capsule can expect improved lung function and enhanced quality of life as they manage their COPD symptoms more effectively. It is essential to understand that while Quikhale FB 200 Capsule is beneficial for long-term management, it does not provide immediate relief for acute symptoms. Therefore, patients are advised to keep a rescue inhaler on hand for sudden breathing difficulties. Overall, Quikhale FB 200 Capsule represents a significant advancement in the treatment of COPD, offering patients a reliable option for managing their condition and improving their daily functioning.